Previous Close · 3.0100 ; Open · 3.0300 ; Day's Range · 2.9500 - 3.0400 ; 52 Week Range · 2.7800 - 13.8500 ; Volume · 52,923 ; Avg. Volume · 137,541 ; Market Cap (intraday) · 123.516M ; PE Ratio (TTM) · -- ; EPS (TTM) · -1.6300 ; 1y Target Est · 13.71
Repare Therapeutics Announces Positive Initial Data at ESMO GI from Phase 1 MINOTAUR Trial Evaluating Lunresertib in Combination with FOLFIRI ; Repare Therapeutics Doses First Patient in Camonsertib Monotherapy Non-Small Cell Lung Cancer Expansion of TRESR Clinical Trial ; Repare (RPTX) Up 14% as Ovarian Cancer Combo Gets Fast Track Tag ; Repare Therapeutics Announces Fast Track Designation Granted by the FDA for Lunresertib in Combination with Camonsertib for the Treatment of Platinum-Resistant Ovarian Cancer
would repare it and i want from you to block ip adress of the destructor who damage this page.thank you second time.--1339861mzb (talk) 11:16, 5 March 2014 (UTC) Your account will be...
Andrej Ivanov/The Globe and Mail Montreal cancer drug developer Repare Therapeutics Inc.... If there’s any success in this IPO I ascribe a lot of the credit to her.”
Repare Therapeutics plans to reduce its workforce by around 25% as the company prioritises operations on its four clinical programmes in oncology indications and shuns new candidate discoveries. The Canadian biotech, which posted a net loss of $34.8m in Q2 financial results earlier this month, said it would focus on the advancement of lunresertib and camonsertib, as well as the RP-1664 and RP-3467 programmes while preclinical research and discovery activities will be drawn back, as per a 28 August press release. ...
Research Reports: RPTX ; Daily – Vickers Top Buyers & Sellers for 06/16/2022 ; Daily – Vickers Top Buyers & Sellers for 06/07/2022 ; Daily – Vickers Top Buyers & Sellers for 01/25/2022
to Repare’s Board of Directors, effective in June 2024 $237.0 million in cash and cash... & MONTREAL--(BUSINESS WIRE)-- Repare Therapeutics Inc. (“Repare” or the “Company”...
Previous Close · 1.6400 ; Open · 1.6680 ; Day's Range · 1.6200 - 1.6680 ; 52 Week Range · 1.4550 - 2.6500 ; Volume · 324,645 ; Avg. Volume · 543,682 ; Market Cap (intraday) · 100.744M ; PE Ratio (TTM) · -- ; EPS (TTM) · -1.2800 ; 1y Target Est · 3.00
& MONTREAL / Jun 04, 2024 / Business Wire / Repare Therapeutics Inc. (“Repare” or the... Lunresertib in combination with camonsertib is currently being evaluated in Repare’s MYTHIC...
Business · Accounting · Accounting questions and answersrepare journal entries to close the temporary accounts and then post to Requirement 6 BGL tab, usin Journal entry worksheet Record the entry to close the revenue account(s). Note: Enter debits before credits.1 Record the entry to close the revenue account(s). 2 Record the entry to close the expense account(s). 3 Record the entry to close the income summary.